The Department of Science and Technology (DOST) said Sunday, Oct. 17, that the results of the virgin coconut oil (VCO) trial at Philippine General Hospital (PGH) which aims to determine the safety and efficacy of VCO as adjunctive therapy for coronavirus disease (COVID-19) cases may be out by end of
The Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI) forged partnership with the University of the Philippines Manila-National Institutes of Health (UP-NIH) to pursue research on nutrition and aging.
(MANILA BULLETIN FILE PHOTO) DOST Secretary Fortunato “B
The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in a
Unfortunate or fortunate? Low number of COVID-19 cases at PGH may delay ongoing VCO clinical trial mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
The Department of Science and Technology (DOST) reported Saturday, June 5, that 64 patients have been enrolled in the clinical trial aimed at looking into the effectiveness of virgin coconut oil (VCO) as an adjunct therapy for hospitalized coronavirus disease (COVID-19) patients.
(Manila Bulletin